These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27789965)

  • 21. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
    Hidayat LK; Hsu DI; Quist R; Shriner KA; Wong-Beringer A
    Arch Intern Med; 2006 Oct; 166(19):2138-44. PubMed ID: 17060545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Evaluation of Pharmacist Interventions in Patients Treated with Anti-methicillin-Resistant Staphylococcus aureus Agents in a Hematological Ward.
    Okada N; Fushitani S; Azuma M; Nakamura S; Nakamura T; Teraoka K; Watanabe H; Abe M; Kawazoe K; Ishizawa K
    Biol Pharm Bull; 2016; 39(2):295-300. PubMed ID: 26830489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sustained-release vancomycin sheet may help to prevent prosthetic graft methicillin-resistant Staphylococcus aureus infection.
    Hirose K; Marui A; Arai Y; Nomura T; Inoue S; Kaneda K; Kamitani T; Fujita M; Mitsuyama M; Tabata Y; Komeda M
    J Vasc Surg; 2006 Aug; 44(2):377-82. PubMed ID: 16890872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical usefulness of the new Japanese glomerular filtration rate equation for initial and individualized dosage adjustment concentrations of vancomycin].
    Kuroda N; Ueshima S; Sato T; Kobiki E; Kawasaki Y; Matsunaga H; Nakura H; Sendo T
    Yakugaku Zasshi; 2012; 132(1):125-33. PubMed ID: 22214587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of the clinical efficacy of vancomycin with the novel pharmacokinetic parameter area under the trough level (AUTL) in elderly patients with hospital-acquired pneumonia.
    Fukumori S; Tsuji Y; Mizoguchi A; Kasai H; Ishibashi T; Iwamura N; To H
    J Clin Pharm Ther; 2016 Aug; 41(4):399-402. PubMed ID: 27144370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bacteriological evaluation of combined effects of vancomycin and beta-lactams. I. Results against methicillin-resistant Staphylococcus aureus].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1993 Nov; 46(11):939-45. PubMed ID: 8309069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A stewardship program's retrospective evaluation of vancomycin AUC24/MIC and time to microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
    Gawronski KM; Goff DA; Brown J; Khadem TM; Bauer KA
    Clin Ther; 2013 Jun; 35(6):772-9. PubMed ID: 23795575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vancomycin Trough Concentration as a Predictor of Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: A Meta-analysis of Observational Studies.
    Prybylski JP
    Pharmacotherapy; 2015 Oct; 35(10):889-98. PubMed ID: 26497475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR) in a patient with septicemia during long-term vancomycin administration.
    Yamaguchi Y; Hanaki H; Yanagisawa C; Ikeda-Dantsuji Y; Hashimoto T; Yazaki H; Sugahara K; Yanagisawa T; Kawajiri H; Sato S; Ishizaki A; Tachihara-Sato R; Takahashi Y; Ono T; Kageyama Y; Kawaguchi T; Tamura A; Hagane K; Sunakawa K
    J Infect Chemother; 2009 Oct; 15(5):274-8. PubMed ID: 19856063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Innovative approaches to optimizing the delivery of vancomycin in individual patients.
    Pai MP; Neely M; Rodvold KA; Lodise TP
    Adv Drug Deliv Rev; 2014 Nov; 77():50-7. PubMed ID: 24910345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delivery of novel vancomycin nanoplexes for combating methicillin resistant Staphylococcus aureus (MRSA) infections.
    Hassan D; Omolo CA; Gannimani R; Waddad AY; Mocktar C; Rambharose S; Agrawal N; Govender T
    Int J Pharm; 2019 Mar; 558():143-156. PubMed ID: 30641177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are Vancomycin Trough Concentrations of 15 to 20 mg/L Associated With Increased Attainment of an AUC/MIC ≥ 400 in Patients With Presumed MRSA Infection?
    Hale CM; Seabury RW; Steele JM; Darko W; Miller CD
    J Pharm Pract; 2017 Jun; 30(3):329-335. PubMed ID: 27074786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potency of DX-619, a novel des-F(6)-quinolone, in haematogenous murine bronchopneumonia caused by methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
    Yanagihara K; Seki M; Izumikawa K; Higashiyama Y; Miyazaki Y; Hirakata Y; Tomono K; Mizuta Y; Tsukamoto K; Kohno S
    Int J Antimicrob Agents; 2006 Sep; 28(3):212-6. PubMed ID: 16887340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacist-Driven MRSA Nasal PCR Screening and the Duration of Empirical Vancomycin Therapy for Suspected MRSA Respiratory Tract Infections.
    Woolever NL; Schomberg RJ; Cai S; Dierkhising RA; Dababneh AS; Kujak RC
    Mayo Clin Proc Innov Qual Outcomes; 2020 Oct; 4(5):550-556. PubMed ID: 33083704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation for optimal dosing of vancomycin in patients with different physical types.
    Hashimoto M; Iketani O; Ichinose N; Enoki Y; Taguchi K; Uno S; Uwamino Y; Hasegawa N; Matsumoto K
    J Infect Chemother; 2019 Sep; 25(9):735-737. PubMed ID: 31126752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased drug resistance of meticillin-resistant Staphylococcus aureus biofilms formed on a mouse dermal chip model.
    Jimi S; Miyazaki M; Takata T; Ohjimi H; Akita S; Hara S
    J Med Microbiol; 2017 Apr; 66(4):542-550. PubMed ID: 28463660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypic and genomic comparisons of highly vancomycin-resistant Staphylococcus aureus strains developed from multiple clinical MRSA strains by in vitro mutagenesis.
    Ishii K; Tabuchi F; Matsuo M; Tatsuno K; Sato T; Okazaki M; Hamamoto H; Matsumoto Y; Kaito C; Aoyagi T; Hiramatsu K; Kaku M; Moriya K; Sekimizu K
    Sci Rep; 2015 Nov; 5():17092. PubMed ID: 26603341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of area under the concentration-time curve to minimum inhibitory concentration ratio on vancomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteraemia.
    Song KH; Kim HB; Kim HS; Lee MJ; Jung Y; Kim G; Hwang JH; Kim NH; Kim M; Kim CJ; Choe PG; Chung JY; Park WB; Kim ES; Park KU; Kim NJ; Kim EC; Oh MD
    Int J Antimicrob Agents; 2015 Dec; 46(6):689-95. PubMed ID: 26555059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of inhaled vancomycin hydrochloride on elimination of methicillin-resistant Staphylococcus aureus].
    Shirai M; Ide K; Sato M; Murakami M; Tanaka Y; Sato A; Chida K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1233-9. PubMed ID: 8583715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploration of optimal dosing regimens of vancomycin in patients infected with methicillin-resistant Staphylococcus aureus by modeling and simulation.
    Lim HS; Chong YP; Noh YH; Jung JA; Kim YS
    J Clin Pharm Ther; 2014 Apr; 39(2):196-203. PubMed ID: 24428720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.